ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,187.70
      0.13%
      US Tech 100
      17,617.63
      0.04%
      Dow Jones
      38,884.26
      0.08%
      Brent Oil
      82.665
      -0.24%
      Bitcoin
      62,516.38
      0.29%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. First Wave BioPharma Inc (FWBI)

      7. First Wave BioPharma Inc (FWBI) News

      FWBI

      First Wave BioPharma (FWBI)

      First Wave BioPharma Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:FWBI
      DateTimeSourceHeadlineSymbolCompany
      12:51PMiHub NewswireFeaturedCannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa
      04/24/20247:00AMGlobeNewswire Inc.First Wave BioPharma Announces Invited Paper for Special Edition on Celiac Disease in Peer-Reviewed Scientific Journal, NutrientsNASDAQ:FWBIFirst Wave BioPharma Inc
      04/17/20247:00AMGlobeNewswire Inc.First Wave BioPharma CEO James Sapirstein to Present at the Planet MicroCap ShowcaseNASDAQ:FWBIFirst Wave BioPharma Inc
      04/15/20247:00AMGlobeNewswire Inc.First Wave BioPharma CEO James Sapirstein to Participate in 2024 Longwood Healthcare Leaders ConferenceNASDAQ:FWBIFirst Wave BioPharma Inc
      03/18/20247:00AMGlobeNewswire Inc.First Wave BioPharma Announces Two Abstracts on Celiac Disease Research Accepted for Presentation at the 2024 Digestive Disease Week (DDW) ConferenceNASDAQ:FWBIFirst Wave BioPharma Inc
      03/14/20246:00AMGlobeNewswire Inc.First Wave BioPharma Announces Completion of Business Combination with ImmunogenX, Adding Phase 3-Ready Latiglutenase to its Late-Stage GI-Focused Clinical PipelineNASDAQ:FWBIFirst Wave BioPharma Inc
      03/05/20245:26PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:FWBIFirst Wave BioPharma Inc
      03/05/20247:00AMGlobeNewswire Inc.First Wave BioPharma to Participate In ‘Fireside Chat’ at the 36th Annual Roth ConferenceNASDAQ:FWBIFirst Wave BioPharma Inc
      03/04/20245:29PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:FWBIFirst Wave BioPharma Inc
      03/04/20248:00AMGlobeNewswire Inc.First Wave BioPharma, Inc. to Raise Approximately $4.0 Million of Gross Proceeds in Registered Direct OfferingNASDAQ:FWBIFirst Wave BioPharma Inc
      02/13/20247:00AMGlobeNewswire Inc.First Wave BioPharma CEO to Present at the BIO CEO & Investor Conference 2024NASDAQ:FWBIFirst Wave BioPharma Inc
      01/23/20247:00AMGlobeNewswire Inc.First Wave BioPharma to Present at the DealFlow MicroCap ConferenceNASDAQ:FWBIFirst Wave BioPharma Inc
      01/18/20244:01PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:FWBIFirst Wave BioPharma Inc
      01/18/202412:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:FWBIFirst Wave BioPharma Inc
      01/17/20244:02PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FWBIFirst Wave BioPharma Inc
      01/17/20247:00AMGlobeNewswire Inc.First Wave BioPharma CEO to Present at the Sequire Investor Summit 2024 in Puerto RicoNASDAQ:FWBIFirst Wave BioPharma Inc
      01/08/20245:14PMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:FWBIFirst Wave BioPharma Inc
      01/04/20245:13PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FWBIFirst Wave BioPharma Inc
      01/04/20245:13PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FWBIFirst Wave BioPharma Inc
      01/04/20248:22AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:FWBIFirst Wave BioPharma Inc
      01/04/20246:00AMGlobeNewswire Inc.First Wave BioPharma Chairman and CEO Issues Letter to Shareholders Highlighting Recent Accomplishments and Outlook for 2024NASDAQ:FWBIFirst Wave BioPharma Inc
      01/03/20247:54PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FWBIFirst Wave BioPharma Inc
      12/28/202312:21PMEdgar (US Regulatory)Form RW - Registration Withdrawal RequestNASDAQ:FWBIFirst Wave BioPharma Inc
      12/27/20235:23PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:FWBIFirst Wave BioPharma Inc
      12/27/202311:55AMGlobeNewswire Inc.First Wave BioPharma Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $4.8 Million Gross Proceeds PricedNASDAQ:FWBIFirst Wave BioPharma Inc
      12/27/20238:04AMEdgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:FWBIFirst Wave BioPharma Inc
      12/27/20236:15AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:FWBIFirst Wave BioPharma Inc
      12/27/20236:00AMGlobeNewswire Inc.First Wave BioPharma Announces Streamlining of Clinical Pipeline with Non-Binding Term Sheet to Sell Niclosamide IBD ProgramNASDAQ:FWBIFirst Wave BioPharma Inc
      12/18/20237:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:FWBIFirst Wave BioPharma Inc
      12/18/20236:00AMGlobeNewswire Inc.First Wave BioPharma Announces Entry into Term Sheet for Business Combination with ImmunogenX Establishing a Leading Late-Stage GI-Focused Biopharmaceutical CompanyNASDAQ:FWBIFirst Wave BioPharma Inc
       Showing the most relevant articles for your search:NASDAQ:FWBI